ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Sponsor : Industry : Chugai Pharma USA

Include trials that are no longer recruiting patients.

3 studies were found.
1.CompletedA blinded study conducted at multiple centers evaluating various doses of an investigational agent (BO-653) against placebo, for safety and effectiveness in preventing post-angioplasty blood vessel re-closure (restenosis) in stented vessels.
Conditions: Graft Occlusion, Vascular; Coronary Restenosis; Atherosclerosis
2.CompletedAn investigational drug (CAL) versus zoledronic acid (Zometa®) in patients with breast cancer
Conditions: Breast Neoplasms; Breast Cancer; Metastasis
3.CompletedSafety and effectiveness of an investigational agent (GM-611) in patients with diabetic gastroparesis
Condition: Gastroparesis

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act